👉HemoHIM ❤️has a total of 13 👉Chapters in the American Medical Library:
👉1st Chapter (respiratory)
👉2nd Chapter (Bone marrow)
👉3rd Chapter (anti-diabetes)
👨4th Chapter (Experiment of Respiratory Tract Infection)
👉5th Chapter (Immune System / Hematopoiesis)
👉6th Chapter (Anti-obesity)
👉7th Chapter (Improving the continued down-regulation of the th1-like immune response)
👉8th Chapter (radiation/tumor treatment)
👉9th Chapter (anti-radiation)
👉10th Chapter (Improving Ovarian Morphology)
👉11th chapter (anti-tumor)
👉12th Chapter (for advanced immunity)
👉13th Chapter (Anti-inflammatory experiment)
👉Relevant information
👉When a doctor wants to increase medical knowledge or to read clinical journals, he will go to the US National Library Of Medicine to collect one of the ways in which he can learn from the clinical research journals in the library.
👉If today, any medical or health food company's products can be awarded with a clinical study, and the journal is published in the American Medical Library. This product must be affirmed, and the price of the product must be unattainable.
👉ATOMY HemoHIM ❤️ has 13 clinical journal reports in the US library, but the price is indeed consumed by the average people!
👉Background story of developing Hemohim immune products:
👉*Hemohim is a 15 doctoral group headed by Dr. Zhao Chengji, a professor of the Korean Atomic Energy Research Institute under the Korean Institute of Atomic Energy, which is a national unit. It is 100% extracted from 30 important Chinese medicines and herbaceous plants in Korea.
👉* After 8 years of clinical trials of cancer patients in atomic hospitals and university affiliated hospitals, investing 5 billion won in research and development expenses to develop the world's latest materials. It does not contain toxic components of traditional Chinese medicine at all, and patients with poor liver can also take it.
👉* After trials for patients, the product has strong quick-acting properties, so it has been approved by the Korea Food and Drug Safety Agency as a health supplement, and has passed the US FDA certification. It has applied for 5 patents in Korea, as well as in the United States. Japan, the United Kingdom, France, Germany, Italy and other countries have also obtained international patented products.
👉* Cancer undergoes a large number of red blood cells and white blood cells during the course of radiation therapy. During the process, nausea and vomiting, loss of appetite, dislocation, memory loss and other symptoms occur, so it is not possible to receive radiation therapy continuously which will cause death.
👉* Hematopoiesis and immunity is greatly reduced and strengthen in the role of HemoHim, increasing the number of red blood cells and white blood cells, improving immunity, so it can continue to receive treatment.
👉* Because of the insufficiency of various bacteria and viruses due to insufficient white blood cells, many problems occur in various organs for a long time.
👉* In short, it is praised as a major discovery in the medical profession in the 20th century. In particular, Hemohim has enhanced the immunity of NK cells with natural killing ability in three kinds of immune cell B-cell NK cells.
Contact me for further details~
Komentar
Posting Komentar